Key result
Atrial septostomy concomitant with PH-specific pharmacotherapy safely reduced pulmonary arterial systolic pressure and improved hemodynamics in three children with VSD and pulmonary hypertension.
Why the study?
Atrial septostomy is typically performed after PH-specific pharmacotherapy fails, but survival benefits may increase if conducted earlier in children with VSD and PH undergoing cardiac surgery.
Does atrial septostomy concomitant with PH-specific pharmacotherapy improve hemodynamics and safety in children with ventricular septal defect and pulmonary hypertension?
Case Report (n=3)
No
Does atrial septostomy concomitant with PH-specific pharmacotherapy improve hemodynamics and safety in children with ventricular septal defect and pulmonary hypertension?
Performing atrial septostomy concomitantly with PH-specific pharmacotherapy as an early treatment in children with VSD and pulmonary hypertension safely reduced pulmonary arterial pressure.
Answers are grounded in this paper and cite their sources.
Supports safety of concomitant atrial septostomy with pharmacotherapy in pediatric VSD-PH; hypothesis-generating and leaves optimal timing open.
Severe pulmonary hypertension (PH) was reported in 22.4% of ventricular septal defect (VSD) and it was mainly seen on a large VSD. Atrial septostomy (AS) could improve the hemodynamic condition and long-term survival of PH patients. Here, three VSD and PH cases in children who underwent AS surgery as their early treatment, concomitant with PH-specific pharmacological treatment were reported. Patient’s hemodynamic and general condition improved with no further complications during the follow-up period. Atrial septostomy was usually conducted after all PH-specific pharmacological interventions failed. However, a study found that the survival benefit of AS was significantly increased if it was conducted before PH-specific pharmacotherapies. Most of the patients in this case received immediate hemodynamic and functional improvement. In this case series, it was reported that the AS procedure could lower the pulmonary arterial pressure and be safely conducted without further complications or death >24 hr post-surgery. Considering the clinical benefit, safety procedure, and improved pulmonary arterial pressure, performing AS procedure concomitant with PH-specific pharmacotherapy as an early treatment for PH patients is recommended.
No takes yet. Share an insight, caveat, or question.
Aribowo et al. (2023) conducted a case report in Ventricular septal defect and pulmonary hypertension (n=3). Atrial septostomy concomitant with PH-specific pharmacotherapy was evaluated on Pulmonary arterial systolic pressure. Atrial septostomy concomitant with PH-specific pharmacotherapy safely reduced pulmonary arterial systolic pressure and improved hemodynamics in three children with VSD and pulmonary hypertension.
Synapse has enriched 10 related papers. Consider them for comparative context: